Lupus Science & Medicine: 10 (Suppl 1)

2023 - Volume 10 - Suppl 1

The 15th International Congress on Systemic Lupus Erythematosus and The 43rd KCR Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)

Organizing Committee

Organizing Committee (6 August, 2023)

Oral Presentation

LO-001 Socioeconomic trends in outcomes of tertiary prevention among patients with systemic connective tissue disorders in Germany (6 August, 2023)
Patrick Brzoska
LO-002 ‘Skin-deep resilience’ in the black women’s experiences living with lupus (BeWELL) study (6 August, 2023)
Kara W Chung, Connor D Martz, Brendan Lutz, Natalie Slopen, Bridget J Goosby, Tamika Webb-Detiege, David H Chae
LO-003 Prevalence of remission according to physician and patient and level of agreement in a real-world multicenter lupus registry (6 August, 2023)
Julia Martínez-Barrio, José María Pego Reigosa, Isabel Castrejón, María Galindo-Izquierdo, Esther Uriarte-Isacelaya, Elena Aurrecoechea Aguinaga, Natalia Mena Vazquez, Irene Altabas, José Carlos Rosas Gómez de Salazar, Silvia Gómez Sabater, Mónica Ibáñez Barcelo, Vicente Torrente Segarra, F Javier Narváez García, Clara Sangüesa Gómez, Joan Calvet Fontova, Mercedes Freire González, Clara Moriano Morales, Carlota Iñiguez, Eva Gloria Tomero Muriel, Ana Pérez Gómez, José Luis Andreu Sánchez, M Jesús García-Villanueva, Tatiana Cobo, Gema Bonilla Hernán, Nuria Lozano Rivas, Loreto Horcada, Carlos Montilla Morales, Francisco Javier Toyos Sáenz de Miera, Lorena Expósito, María Esther Ruiz Lucea, José Eloy Oller, Ángela Pecondón Español, Ricardo Blanco Alonso, Sergio Machín, Eva Salgado, Irene Carrión Bárbera, Raúl Menor Almagro, Jaime Calvo Alen, Alejandro Muñoz Jiménez, Jorge Fragio Gil, Iñigo Rúa-Figueroa Fdez de Larrinoa
LO-004 Frequency and determinants of flare and persistently active disease in a large multinational prospective lupus cohort (6 August, 2023)
Yanjie Hao, Rangi Kandane-Rathnayake, Ning Li, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Yuan An, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Zhuoli Zhang, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Fiona Goldblatt, Sean O’Neill, Kristine Ng, Annie Law, Duminda Basnayake, Nicola Tugnet, Sunil Kumar, Michael Tee, Cherica Tee, Yoshiya Tanaka, CS Lau, Vera Golder, Alberta Hoi, Eric Morand, Shereen Oon, Mandana Nikpour
LO-005 Urinary L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multiple ethnicities (6 August, 2023)
Yiwei Shen, Kamala Vanarsa, Zhihua Yin, Ramesh Saxena, Michelle Petri, Nan Shen, Zhizhong Ye, Chandra Mohan, Huihua Ding
LO-006 Change in urinary biomarkers at three months predicts 1-year treatment response of lupus nephritis better than proteinuria (6 August, 2023)
Andrea Fava, Jill Buyon, Laurence Magder, Jeffrey Hodgin, Avi Rosenberg, Dawit Demeke, Deepak Rao, Arnon Arazi, Alessandra Ida Celia, Chaim Putterman, Jennifer Anolik, Jennifer Barnas, Maria Dall’Era, David Wofsy, Richard Furie, Diane Kamen, Kenneth Kalunian, Judith A James, Joel Guthridge, Mohamed G Atta, Jose Monroy-Trujillo, Derek Fine, Robert Clancy, H Michael Belmont, Peter Izmirly, William Apruzzese, Daniel Goldman, Celine Berthier, Paul Hoover, Nir Hacohen, Soumya Raychaudhuri, Anne Davidson, Betty Diamond, The Accelerating Medicines Partnership in ra/sle, Michelle Petri
LO-007 EZH2 deficiency in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in mice (6 August, 2023)
Xiaoqing Zheng, Mikhail Dozmorov, Colleen Strohlein, Sheldon Bastacky, Amr Sawalha
LO-008 MEF2D (Mef2d) expression in CD4 T cells influences humoral autoimmunity by regulating follicular helper T cell differentiation and function (6 August, 2023)
Ye-Ji Kim, Jeein Oh, Chan-Johng Kim, Chang-Hee Suh, Sin-Hyeog Im, Youn Soo Choi
LO-042 High genetic risk load for systemic lupus erythematosus in antinuclear antibody-positive individuals at the preclinical stage (6 August, 2023)
Sehwan Chun, So-Young Bang, Young-Chang Kwon, Soo-Kyung Cho, Chan-Bum Choi, Yoon-Kyoung Sung, Ji-Young Han, Tae-Hwan Kim, Jae-Bum Jun, Dae Hyun Yoo, Hye-Soon Lee, Kwangwoo Kim, Sang-Cheol Bae
LO-009 Responsiveness of the CLASI to alopecia and mucous membrane involvement: a retrospective study of prospectively collected data (6 August, 2023)
Anisha Jobanputra, Rui Feng, Julianne Kleitsch, Josef Concha, Victoria Werth
LO-010 Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus (6 August, 2023)
Chi-Chiu Mok, Yuen Kwan Chung, Carolyn Lee, Ling Yin Ho, Chi Hung To
LO-012 The innate immune checkpoint NLRP12 represses IFN signatures and attenuates the progression of lupus nephritis (6 August, 2023)
Szu-Ting Chen, Yen-Po Tsao, Fang-Yu Tseng
LO-013 Novel pathogenetic mechanisms mediated by dysregulation of TRIM21-STING-type I interferon axis in lupus (6 August, 2023)
Da Som Kim, Youngjae Park, Mi-La Cho, Seung-Ki Kwok
LO-014 Mechanistic interrogation of STAT1 gain-of-function syndrome provides new insights into human lupus pathogenesis (6 August, 2023)
Andrea Largent, Jane Buckner, David Rawlings, Shaun Jackson
LO-015 Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in a phase 2 trial in systemic lupus erythematosus (SLE): achievement of sustained SRI(4), BICLA, and dual responses over 48 weeks (6 August, 2023)
Richard Furie, Cristina Arriens, Kenneth B Kalunian, Marilyn Pike, Ronald van Vollenhoven, Coburn Hobar, Ayanbola Elegbe, Samantha Pomponi, Subhashis Banerjee, Shalabh Singhal, Thomas Wegman, Eric Morand
LO-016 The multifaceted immunomodulatory properties of cenerimod, a selective S1P1 receptor modulator, target three key aspects of SLE pathogenesis (6 August, 2023)
Thomas F Hoyler, Daniel S Strasser, Ouali Berkani, Clelia Cahuzac, Peter Cornelisse, Mark J Murphy, Marianne M Martinic
LO-017 Zetomipzomib (KZR-616) demonstrates anti-inflammatory and immunomodulatory potential in patients with active lupus with or without lupus nephritis: results from the open-label Phase 1b/2 MISSION study (6 August, 2023)
Brad Rovin, Amit Saxena, Richard Leff, Elaine Li, Eunmi Park, Noreen Henig
LO-018 Effect of COVID-19 infection on disease flares and herpes zoster reactivation in patients with SLE: a case-control study (6 August, 2023)
Chi-Chiu Mok, Ching Lam Cheung, Ling Yin Ho, Kar Li Chan, Sau Mei Tse, Chi Hung To
LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study (6 August, 2023)
Emelie Khilgren Olsson, R Naveen, Elena Nikiphorou, Julius Lindblom, Sreoshy Saha, Syahrul Sazliyana Shaharir, Wanruchada Katchamart, Phonpen Akarawatcharangura Goo, Lisa Traboco, Yi-Ming Chen, Kshitij Jagtap, James Lilleker, Arvind Nune, John Pauling, Chris Wincup, Vishwesh Agarwal, Dey Dzifa, Carlos Enrique Toro Gutierrez, Carlo Vinicio Caballero, Hector Chinoy, Vikas Agarwal, Rohit Aggarwal, Latika Gupta, Ioannis Parodis
LO-020 Association between corticosteroid use and risk of avascular necrosis in patients with systemic lupus erythematosus: a nested case-control study (6 August, 2023)
Jongmin Lee, Seung-Hun You, Yu-Seon Jung, Yoon-Kyoung Sung, Soo-Kyung Cho, Sun-Young Jung
LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus (SLE) (6 August, 2023)
Shin-Seok Lee, Stanislav Ignatenko, Alexander Gordienko, Josefina Hernandez, Nancy Levin, Pongthorn Narongroeknawin, Katarzyna Romanowska-Prochnicka, Nan Shen, Hanna Ciferska, Masanari Kodera, Cheng-Chung Wei, Piotr Leszczynski, Joung Liang Lan, Rafal Wojciechowski, Tunde Tarr, Elena Vishneva, Yi Hsing Chen, Yuko Kaneko, Stephanie Finzel, Alberta Hoi, Masato Okada, Ajchara Koolvisoot, Lie Dai, Hiroshi Kaneko, Bernadette Rojkovich, Lingyun Sun, Eugeny Zotkin, Berta Paula magallares, Tirtha Sengupta, Carole Sips, Stephan Oliver
LO-022 Modulation of inflammation in systemic lupus erythematosus utilizing mesenchymal stem cell-derived secretome (6 August, 2023)
Sung Soo Ahn, Chin Hee Mun, Taejun Yoon, Eunhee Ko, Soo Jung Kim, Yong-Beom Park
LO-043 Single-cell RNA sequencing reveals the dynamics of circulating immune cells in SLE patients treated with belimumab (6 August, 2023)
Christine Suh-Yun Joh, So-Young Bang, Sang-Cheol Bae, Hyun Je Kim, Hye-Soon Lee
LO-023 Remission of lupus nephritis: the trajectory of histologic response in successfully treated patients (6 August, 2023)
Ana Malvar, Valeria Alberton, Bruno Lococo, Maria Lourenco, Joaquin Martinez, Mauro Elencwajg, Paola Pirruccio, Haikady Nagaraja, Brad Rovin
LO-024 Association between severe non-adherence to hydroxychloroquine and SLE flares, damage, and mortality in 660 patients from the SLICC inception cohort (6 August, 2023)
Yann Nguyen, Benoît Blanchet, Murray B Urowitz, John G Hanly, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Ann E Clarke, Sasha Bernatsky, Daniel J Wallace, David A Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald FVan Vollenhoven, Cynthia Aranow, Véronique Le Guern, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lin, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askanase, Jill Buyon, Nathalie Costedoat-Chalumeau
LO-025 Increasing pre-eclampsia knowledge and higher prevalence of aspirin use in SLE with a specific educational tool: interim analyses of a randomized controlled trial (6 August, 2023)
Joo-Young (Esther) Lee, Arielle Mendel, Isabelle Malhamé, Sasha Bernatsky, Evelyne Vinet
LO-026 Hydroxychloroquine use in pregnant women with systemic lupus erythematosus and major congenital malformations in the offspring (6 August, 2023)
Viet Ngoc Nguyen, Elisabet Svenungsson, Annica Dominicus, Karin Hellgren, Julia F Simard, Elizabeth Arkema
LO-027 COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus (6 August, 2023)
Nefeli Giannopoulou, Latika Gupta, Laura Andreoli, Daniele Lini, Elena Nikiphorou, Rohit Aggarwal, Vikas Agarwal, Ioannis Parodis
LO-028 Functional dissection of dysregulated enhancers influencing SLE critical gene expression (6 August, 2023)
Guojun Hou, Xinyi Zhu, Yutong Zhang, Zhaorui Cheng, Nan Shen
LO-029 Longitudinal single-cell transcriptomic analysis of peripheral blood in lupus nephritis reveals different immune cell gene signatures depending on treatment response (6 August, 2023)
Woo-Joong Kim, Hye-Soon Lee, So-Young Bang, Bo-Kyeong Kang, Dae Jin Park, Young Bin Joo, Mimi Kim, Hyunsung Kim, Sung Yul Park, Woong-Yang Park, Eui-Cheol Shin, Sang-Cheol Bae
LO-030 Functional characterization of 2p22.3 locus identifies PARP-1 as an allele-specific interactor at rs13385731 which mechanistically regulates RasGrp3 expression in contributing SLE susceptibility (6 August, 2023)
Swapan Nath
LO-031 Working towards a core minimal dataset for systemic lupus erythematosus studies (6 August, 2023)
Stephen Mcdonald, Jialin Teng, Michelle Barraclough, Ian Bruce
LO-032 Increased IFITM gene-signatures in age-associated B and plasma cells define non-response to mycophenolate mofetil in systemic lupus erythematosus (6 August, 2023)
Raul Lopez-Dominguez, Juan Antonio Villatoro-Garcia, Concepcion Marañon, Daniel Goldman, Michelle Petri, Pedro Carmona-Saez, Marta Alarcon-Riquelme, Daniel Toro-Domínguez
LO-033 Towards a novel clinical outcome assessment for systemic lupus erythematosus trials – first outcomes of an international consensus process (6 August, 2023)
Kathryn Connelly, Laura Eades, Rachel Koelmeyer, Darshini Ayton, Vera Golder, Rangi Kandane-Rathnayake, Kate Gregory-Wong, Hermine Brunner, Laurie Burke, Laurent Arnaud, Anca Askanase, Cynthia Aranow, Edward Vital, Guillermo Pons-Estel, Khadija Dantata, Ying Sun, Yoshiya Tanaka, Simon Lee, Youmna Lahoud, Alan Friedman, Kenneth Kalunian, Qing Zuraw, Victoria Werth, Sandra Garces, Eric Morand
LO-034 Performance of combining eye sign and functional magnetic resonance imaging in diagnosing patients with neuropsychiatric systemic lupus erythematosus (6 August, 2023)
Jenny Lin-Hong Shi
LO-035 The effects and molecular mechanisms of TRAF5 on pulmonary artery endothelial cells in patients with systemic lupus erythematosus associated pulmonary arterial hypertension (6 August, 2023)
Xiaoyue Deng, Junyan Qian, Ranran Wang, Jiuliang Zhao, Qian Wang, Xiaofeng Zeng, Tianyi Yuan, Mengtao Li
LO-036 Inhibition of transcolbalamin2 overexpression ameliorated renal injury in systemic lupus erythema via reducing pathogenic Tfh and B cell infiltration (6 August, 2023)
Baoyi Liu, Ke Xu, Ang Li, Jingkai Xu, Yong Cui
LO-037 Altered peripheral non-classic monocyte and NKT counts and CD8+ TCR diversity of systemic lupus erythematosus identified via integrated high-dimensional flow cytometry, CyTOF, metabolic profiling and TCR clonality analyses (6 August, 2023)
Anselm Mak, Kok Siong Ang, Jinmiao Chen
LO-038 ETV5 promotes follicular helper T cell differentiation and lupus pathogenesis (6 August, 2023)
Jiho Park, Yoontae Lee
LO-039 Vitamin D3 mitigates immune system alterations caused by activation of myeloid dendritic cells in SLE (6 August, 2023)
Mingfang Li, Li Luo, Chuanchuan Lin, Bing Ni, Liyun Zou, Zhiqiang Song, Fei Hao, Na Luo
LO-040 The efficacy of tacrolimus in antiphospholipid antibodies associated thrombocytopenia: a prospective cohort study (6 August, 2023)
Yu Shi, Jiuliang Zhao, Xiaofeng Zeng
LO-041 Severe thrombocytopenia is associated with adverse pregnancy outcomes in obstetric antiphospholipid syndrome (6 August, 2023)
Jiayang Jin, Chun Li

Short Oral Presentation

LSO-001 Modulating T-bet-promoted energy metabolism in pathogenic age/autoimmune-associated B cells ameliorates lupus autoimmunity (6 August, 2023)
Dai Dai, Xiaxia Han, Nan Shen
LSO-002 The transcriptional factor Pbx1 adjusts peripheral B cell homeostasis to constrain lupus autoimmunity (6 August, 2023)
Dai Dai, Shuangshuang Gu, Nan Shen
LSO-003 Effects of progesterone-induced blocking factor 1 on the alleviation of lupus nephritis in MRL/lpr mice (6 August, 2023)
Young Eun Kim, Do Hoon Kim, Mi Ryeong Jeong, Eun-Ju Lee, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Chang Ohk Sung, Hyun Jae Shim, Yoo Sook Cho, Yong-Gil Kim
LSO-004 cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus (6 August, 2023)
Sarinya Kumpunya, Arthid Thim-Uam, Chisanu Thumarat, Asada Leelahavanichkul, Nuttiya Kalpongnukul, Naphat Chantaravisoot, Trairak Pisitkun, Prapaporn Pisitkun
LSO-005 Type I interferon affects Th22 cell differentiation participated in the pathogenesis of lupus nephritis (6 August, 2023)
Haojie Xu, Rong Li, Lidan Zhao
LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders (6 August, 2023)
Shalini Paliwal, Dipti Thakkar, Wen Jie Chin, Warren Lee, Jie Ying Jacklyn Neo, Brendon Hanson, Konrad Paszkiewicz, Piers Ingram, Jerome Boyd-Kirkup
LSO-007 Trimeric oligonucleotides ameliorate disease in a mouse model of CLE-like inflammatory skin disease (6 August, 2023)
Mary Speir, W Samantha N Jayasekara, Sunil Sapkota, Arwaf Alharbi, Olivier F Laczka, Michael P Gantier
LSO-098 Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus (6 August, 2023)
Sumei Tang, Yushu Wang, Xiangbo Ma, Xiaohong Xiang, Xinhua Zhou, Yan Li, Yuan Jia, Fanlei Hu, Yingni Li
LSO-008 Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients (6 August, 2023)
Romain Stammler, Nathalie Costedoat-Chalumeau
LSO-009 The impact of high-risk antiphospholipid antibodies profile on major organ damage progression in systemic lupus erythematosus: CSTAR multiple prospective cohort study (6 August, 2023)
Yufang Ding, Jiuliang Zhao, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng
LSO-010 Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibodies associated adverse pregnancy outcomes: a based on a 13-year longitudinal cohort study (6 August, 2023)
Yin Long, Jiuliang Zhao, Mengtao Li, Xinping Tian, Xiaofeng Zeng
LSO-013 Metabolomics analysis identifies biomarkers for APS and suggests potential new pathway for APS pathogenesis (6 August, 2023)
Yongjing Luo, Chun Li, Zhanguo Li, Yu Zuo
LSO-014 Clinico-pathological association of serum CD44 level in lupus nephritis patients (6 August, 2023)
Susan Yung, Lucy Gao, Tak Mao Chan
LSO-015 Deucravacitinib reduces interferons, B cell pathways, and serological biomarkers of systemic lupus disease activity: pharmacodynamic analysis from the phase 2 PAISLEY study (6 August, 2023)
J Michelle Kahlenberg, Ignacio Sanz, Chun Wu, Yanhua Hu, Jin Hyang Kim, Shalabh Singhal, Ian M Catlett
LSO-016 Activated leukocyte cell adhesion molecule, hemopexin, and peroxiredoxin 6 as a potential urine biomarker for Korean patients with systemic lupus erythematosus (6 August, 2023)
Ji-Won Kim, Chang-Hee Suh, Wook-Young Baek, Sang-Won Lee, Ju-Yang Jung, Hyoun-Ah Kim
LSO-017 Anti-TCP1 antibody is the potential biomarker of systemic lupus erythematosus (SLE) (6 August, 2023)
Sang-Won Lee, Seung-Ju Kim, Wook-Young Baek, Ho-Chul Kang, Chang-Hee Suh
LSO-018 iC3b/C3 ratios more strongly correlate with SLE disease activity in African- Americans compared with whites (6 August, 2023)
Deepali Sen, Vibeke Strand, Qiang Fu, John Atkinson, Alfred Kim
LSO-019 Effect of air pollutant exposure on disease activity of systemic lupus erythematous: a prospective longitudinal study from Korea (6 August, 2023)
Ji-Hyoun Kang, Sung-Eun Choi, Dong-Jin Park, Han Joo Baek, Hyo-Jin Choi, Jae Hyun Jung, Shin-Seok Lee
LSO-020 Intervention to improve medication adherence among patients with systemic lupus erythematosus (6 August, 2023)
Kai Sun, Nneka Molokwu, Emily Hanlen-Rosado, Amy Corneli, Kathryn Pollak, Jennifer Rogers, Rebecca Sadun, Lisa Criscione-Schreiber, Jayanth Doss, Hayden Bosworth, Megan Clowse
LSO-021 Epidemiology and survival of SLE in the last decade: data from a large population-based study in northeastern Italy (6 August, 2023)
Margherita Zen, Laura Salmaso, Claudio Barbiellini Amidei, Ugo Fedeli, Stefania Bellio, Mario Saia, Andrea Doria
LSO-022 Adverse childhood experiences and disease activity: the role of trauma in the black women’s experiences living with lupus (BeWELL) study (6 August, 2023)
Kara W Chung, Evelyn A Hunter, John Bridges, Emily A Smitherman, Connor D Martz, Maria I Danila, David H Chae
LSO-023 Clinical characteristics of SARS-CoV-2 infection in patients with systemic lupus erythematosus in Argentina: data from the SAR-COVID national registry (6 August, 2023)
Carolina Isnardi, Karen Roberts, Yohana Tissera, Ingrid Petkovic, Guillermo Berbotto, Carla Gobbi, Romina Tanten, Karina Cogo, Cecilia Asnal, Andrea Baños, Florencia Vivero, Maria Marcela Schmid, Ma Alicia Lazaro, Noelia German, Lorena Takashima, Julia Scafati, Marina Laura Werner, Luciana Casalla, Carla Matellan, Diana Marcela Castrillon, Florencia Rodriguez, Sebastián Moyano, Maria Luz Martin, Vanesa Cosentino, Natalia Herscovich, Elda Rossella Tralice, Tatiana Barbich, Dora Lia Vasquez, Emilio Buschiazzo, Pablo Maid, Ana Carolina Ledesma, Victor Yohena, Gimena Gomez, Rosana Quintana, Guillermo J Pons-Estel
LSO-024 Comparison of clinical characteristics and outcomes in patients with systemic lupus erythematosus: a cross-national study (6 August, 2023)
Soo-Kyung Cho, Gaobin Bao, Sang-Cheol Bae, Sung Sam Lim
LSO-025 Comparison between add-on pulse methylprednisolone versus medium to high dose glucocorticoids alone in Thai patients with proliferative lupus nephritis receiving monthly pulse intravenous cyclophosphamide (6 August, 2023)
Thananant Trongkamolthum, Boonjing Siripaitoon, Porntip Intapiboon
LSO-026 Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: results from a real-world CSTAR cohort study (6 August, 2023)
Wei Bai, Mengtao Li
LSO-027 Predictors of long-term renal survival and mortality in patients with biopsy-proven lupus nephritis: a prospective cohort study (6 August, 2023)
Jung-Min Shin, So-Young Bang, Jiyoung Lee, Hye-Soon Lee, Sang-Cheol Bae
LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab (6 August, 2023)
Ioannis Parodis, Julius Lindblom, Nurşen Çetrez, Leonardo Palazzo, Henri Ala, Frédéric Houssiau, Christopher Sjöwall, Brad Rovin
LSO-029 Predictors of renal relapse in Korean patients with lupus nephritis: over a 35-year period at a single center (6 August, 2023)
Howook Jeon, Jennifer Lee, Seung-Ki Kwok, Ji Hyeon Ju, Wan-Uk Kim, Sung-Hwan Park, Su-Jin Moon
LSO-030 Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab (6 August, 2023)
Alvaro Gomez, Sandra Jägerback, Ioannis Parodis
LSO-100 Does early complete remission preclude adverse outcomes in lupus nephritis? (6 August, 2023)
Konstantinos Tselios, Dafna Gladman, Jiandong Su, Murray Urowitz
LSO-031 Association of serologic and clinical low disease activity states with outcomes in a large multi-national lupus cohort (6 August, 2023)
Yanjie Hao, Shereen Oon, Ning Li, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Yuan An, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Zhuoli Zhang, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Fiona Goldblatt, Sean O’Neill, Kristine Ng, Annie Law, Duminda Basnayake, Nicola Tugnet, Sunil Kumar, Michael Tee, Cherica Tee, Yoshiya Tanaka, CS Lau, Vera Golder, Alberta Hoi, Rangi Kandane-Rathnayake, Eric Morand, Mandana Nikpour
LSO-032 Predictors of first hospitalizations due to disease activity and infections in systemic lupus erythematosus patients (6 August, 2023)
Rosana Quintana, Romina Nieto, Rosa Serrano Morales, Manuel F Ugarte-Gil, Guillermina B Harvey, Daniel Wojdyla, José A Gómez-Puerta, Mercedes A García, Luis J Catoggio, Verónica Saurit, Cristina Drenkard, Nilzio Antonio Da Silva, Fernando Cavalcanti, Eduardo Borba, Emilia Sato, Oscar Neira, Loreto Massardo, Gloria Vásquez, Luis Alonso Gonzalez, Marlene Guibert-Toledano, Luis Silveira, Ignacio García de la Torre, María Josefina Sauza del Pozo, Rosa Chacon, Graciela S Alarcón, Ashley Orillion, Urbano Sbarigia, Federico Zazzetti, Bernardo A Pons-Estel, Guillermo Pons-Estel
LSO-033 Comparison of the systemic lupus international collaborating clinics frailty index (SLICC-FI) and the FRAIL scale for identifying frailty among individuals with systemic lupus erythematosus (6 August, 2023)
Alexandra Legge, Sarah Lieber, John Hanly
LSO-034 Association of latent tuberculosis infection with clinical and serological parameters in systemic lupus erythematosus- a prospective observational study (6 August, 2023)
Gayathri Ms, Chengappa Kavadichanda, Molly Mary Thabah, Sonali Sarkar, Prakash Babu Narasimhan
LSO-036 Cluster analysis and subphenotype stratification in lupus erythematosus based on data from the Asia Pacific lupus collaboration cohort (APLC-CASTLE) (6 August, 2023)
Shirley Chiu Wai Chan, Worawit Louthrenoo, Alberta Hoi, Shue Fen Luo, Yeong-Jian Jan Wu, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Sandra Navarra, Leonid Zamora, Sargunan Sockalingam, Yuan An, Zhanguo Li, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Jun Kikuchi, Tsutomu Takeuchi, BMDB Basnayake, Madelynn Chan, Kristine Ng, Nicola Tugnet, Sunil Kumar, Shereen Oon, Fiona Goldblatt, Sean O’Neill, Kathryn Gibson, Naoaki Ohkubo, Yoshiya Tanaka, Sang-Cheol Bae, Rangi Kandane-Rathnayake, Mandana Nikpour, Vera Golder, Eric Morand, Chak Sing Lau
LSO-037 STING/TMEM173 mutation in systemic lupus erythematosus: from animal model to intrinsic human genetics (6 August, 2023)
Pichpisith Vejvisithsakul, Satima Wanachate, Pintip Ngamjanyaporn, Chisanu Thumarat, Thanitta Suangtamai, Asada Leelahavanichkul, Nattiya Hirankan, Trairak Pisitkun, Soren Paludan, Prapaporn Pisitkun
LSO-038 Nlrp12 deficiency mice present severer lupus nephritis in lupus prone model and pristane-induced lupus like model (6 August, 2023)
Yen Po Tsao, Szu Ting Chen
LSO-039 Proteomic analysis of cutaneous lupus erythematosus and dermatomyositis dermal infiltrate reveals differentially expressed canonical pathways (6 August, 2023)
Aliisa Häyry, Timothy B Niewold, Alexander Meves, Julia S Lehman, Karin Popovic-Silwerfeldt, Cristine M Charlesworth, Benjamin Madden, Elisabet Svenungsson, Vilija Oke
LSO-040 Mitochondria promotes autoimmune plasmablasts generation in lupus (6 August, 2023)
Sung Hoon Jang, Joo Sung Shim, Jieun Kim, Ho-Keun Kwon, Jason Jungsik Song
LSO-041 Loss-of-function NADPH oxidase variants promote lupus pathogenesis by modulating B cell-intrinsic TLR signals (6 August, 2023)
Aaron Liu, Mridu Acharya, Shaun Jackson
LSO-101 A spatially-resolved single cell resolution atlas of pediatric lupus nephritisuncovers complex interactions between stromal and infiltrating immune cells (6 August, 2023)
Sarah Baxter, Patrick Danaher, Daryl Okamura, Shaun Jackson
LSO-043 Urinary neutrophil gelatinase-associated lipocalin (NGAL) as a mediator of the association between particulate matter exposure and disease activity in systemic lupus erythematosus (6 August, 2023)
Ji-Hyoun Kang, Sung-Eun Choi, Dong-Jin Park, Han Joo Baek, Hyo-Jin Choi, Jae Hyun Jung, Shin-Seok Lee
LSO-044 Sphingolipids are potential diagnostic biomarkers for Korean patients with systemic lupus erythematosus (6 August, 2023)
Ji-Won Kim, Ju-Yang Jung, Hyoun-Ah Kim, Chang-Hee Suh
LSO-045 Multiple molecular biomarkers that predict response to treatment in lupus nephritis (6 August, 2023)
Dae Jin Park, Young-Bin Joo, Eunwoo Nam, Jiyoung Lee, So-Young Bang, Hye-Soon Lee, Sang-Cheol Bae
LSO-046 Metabolomic analysis for the unique profile and novel biomarkers of neuropsychiatric systemic lupus erythematosus (6 August, 2023)
Xue Li, Yixue Guo, Huaqing Lu, Wenwen Pei, Yifan Wang, Jing He, Xiaolin Sun
LSO-047 Utility of autoantibody against an UCH-L1 epitope as a serum diagnostic marker for neuropsychiatric systemic lupus erythematosus (6 August, 2023)
Yixue Guo, Xue Li, Xiaolin Sun
LSO-102 The correlation between interleukin-6 (IL-6) and the development of systemic lupus erythematosus (SLE) in universiti sains Malaysia (USM) (6 August, 2023)
Mohamed Shafi Mahboob Ali
LSO-048 Incidence, prevalence, and burden of systemic lupus erythematosus in urban China, 2013–2017: a nationwide population-based study (6 August, 2023)
Mucong Li, Chaiquan Li, Mengzhuo Cao, Ke Lu, Xun Tang, Pei Gao, Mengtao Li, Xiaofeng Zeng
LSO-049 Greater social vulnerability associated with greater glucocorticoid use in patients with SLE (6 August, 2023)
Avira Som, Lily Mcmorrow, Ling Chen, Deepali Sen, Alia El-qunni, Elizabeth Baker, Alfred Kim
LSO-050 Mortality-rate in juvenile-onset systemic lupus erythematosus in perspective: results from a population-based cohort study in Norway (6 August, 2023)
Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, Torild Garen, Antonella Botea, Nenad Damjanic, Gro Wivestad, Heidi Kverneggen Øvreås, Thea Bøe, Anniken Orre, Sella Aarrestad Provan, Øyvind Molberg, Karoline Lerang
LSO-051 Smoking at onset of systemic lupus erythematosus compared with age-matched controls (6 August, 2023)
Anniken Orre, Torhild Garen, Karoline Lerang
LSO-052 Comparative cardiovascular risk in patients with older-onset systemic lupus erythematosus: a nationwide retrospective cohort study in Korea (6 August, 2023)
Jungyong Han, Soo-Kyung Cho, Yena Jeon, Gaeun Kang, Hyoungyoung Kim, Sun-Young Jung, Eun Jin Jang, Yoon-Kyoung Sung
LSO-103 Childhood-onset systemic lupus erythematosus: long-term outcomes in a large multi-ethnic Ontario cohort (6 August, 2023)
Ha-Seul Jeoung, Kuan Liu, Roberta Berard, Wesley Fidler, Janet Pope, Johannes Roth, Carter Thorne, Andrea Knight, Linda Hiraki, Earl Silverman, Deborah Levy
LSO-053 Elevated expression of Hsa_circ_0000479 in neutrophils correlates with features of systemic lupus erythematosus (6 August, 2023)
Ranran Yao, Liling Xu, Huaqun Zhu, Gong Cheng, Ziye Wang, Ruyu Liang, Wenwen Pei, Renge Liang, Yuan Jia, Hua Ye, Fanlei Hu, Yin Su
LSO-054 Genetic fine mapping of independent variants in MHC region associated with predisposition and clinical feature of systemic lupus erythematosus in Han Chinese population (6 August, 2023)
Ke Xue, Yong Cui
LSO-055 Genetic contributions to neuropsychiatric systemic lupus erythematosus (6 August, 2023)
Soojin Cha, Ga Young Ahn, Hye-Soon Lee, Sang-Cheol Bae, So-Young Bang
LSO-056 Impaired function of neutrophil cytosolic factor 2 (NCF2) may participates in lupus from multiple pathways (6 August, 2023)
Ang Li, Baoyi Liu, Jingkai Xu, Ke Xue, Yong Cui
LSO-057 Association between TNFSF13B gene polymorphism and serum BAFF levels with disease activity in SLE patients (6 August, 2023)
Nadia Gita Ghassani, Gabriel Bagus Kennardi, Desi Reski Fajar, Melisa Intan Barliana, Edhyana Sahiratmadja, Laniyati Hamijoyo
LSO-058 Changes in clinical features and mortality of early (1998–2007) and late cohort (2008–2017) of systemic lupus erythematosus: a prospective inception cohort study (6 August, 2023)
Young Bin Joo, Jiyoung Lee, So-Young Bang, Hye-Soon Lee, Sang-Cheol Bae
LSO-059 Systemic lupus erythematosus (SLE) patients in Auckland: epidemiology and attainment of lupus low disease activity state (LLDAS) (6 August, 2023)
Nikki Tugnet, Nisha Prashar, Sunil Kumar, Mark Sapsford, Kristine (Pek Ling) Ng
LSO-060 Self-efficacy is associated with a lower probability of damage accrual in patients with systemic lupus erythematosus (6 August, 2023)
Manuel Ugarte-Gil, Rocio Gamboa-Cardenas, Victor Pimentel-Quiroz, Cristina Reategui-Sokolova, Claudia Elera-Fitzcarrald, Erika Noriega, Zoila Rodriguez-Bellido, Cesar Pastor-Asurza, Graciela S Alarcon
LSO-062 Worse outcomes linked to ethnicity for the early treatment of refractory SLE: results from the BILAG-BR (6 August, 2023)
Sarah Dyball, Mia Rodziewicz, Emily Sutton, Ben Parker, Ian N Bruce
LSO-104 Impact of time to remission, flares and exposure to immunosuppressives on the development of advanced chronic kidney disease (stage IV or worse) in lupus nephritis (6 August, 2023)
Konstantinos Tselios, Dafna Gladman, Jiandong Su, Murray Urowitz
LSO-064 Disease -modifying effect and long-term safety data of belimumab in patients with SLE: a single centre retrospective analysis (6 August, 2023)
Takehiro Nakai, Sho Fukui, Masato Okada
LSO-065 Belimumab in combination with antimalarial agents prevent renal flares in patients with systemic lupus erythematosus and moderate-to-high extra-renal activity: results from four randomised clinical trials (6 August, 2023)
Alvaro Gomez, Sandra Jägerback, Christopher Sjöwall, Ioannis Parodis
LSO-066 Spanish national regsitry of belimumab in patients with systemic lupus erythematosus (6 August, 2023)
Vicente Aldasoro, María Laiño, Mónica Enguita, Javier Loricera, Clara Moriano, Carmen Lasa, Vanesa Calvo, Francisco Javier Narváez, Pablo Navarro, Ivette Casafont, Judit Font, Adela Gállego, Irene Carrión, Patricia Quiroga, Santos Castañeda, Ángel García, Joaquín Belzunegui, Juán Ramón de Dios, Samuel Hernández, Sergi Heredia, Aaron Fariña, Francisco Navarro, Rafaela Ortega, Leticia del Olmo, Valvanera Pinillos, Eztizen Labrador, María Carmen Ortega, Patricia Castro, Juan Blanco, Marcos Paulino, María Ángeles Matías, Cilia Peralta, Silvia García, Jordi Camins, Ana Urruticoechea, Miguel Medina, Piter Cossio, Eva Pérez, Blanca Varas, Carlos Vázquez, Nuria Vegas, Olga Rusinovich, Emilio Giner, José Ramón Lamúa
LSO-068 Association between organ-specific safety of estrogens in lupus erythematosus national assessment-systemic lupus erythematosus (SLE) disease activity index (SELENA-SLEDAI) response to belimumab and SF-36v2 and FACIT-fatigue scores in patients with SLE (6 August, 2023)
Regina Rendas-Baum, Wen-Hung Chen, Seth Anderson, Christine Henning, Anne Hammer, Mark Kosinski
LSO-069 Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice (6 August, 2023)
Beatriz Frade-Sosa, Tarek Carlos Salman-Monte, Javier Narváez, Irene Peralta, Sebastian Sandoval, Berta Magallares, Sergi Heredia, Nuria Sapena, Anne Riveros-Frutos, Alex Olivé, Hector Corominas, Josefina Cortés-Hernández, Jose A Gómez-Puerta
LSO-105 D-ALW nanoparticles ameliorate lupus nephritis in MRL/lpr mice (6 August, 2023)
Yaqi Wang, Huixia Wang, Yumin Xia
LSO-071 Correlation of traditional and SLE related risk factors with carotid intima media thickness as early MACEs predictor in SLE patients: a systematic review and meta-analysis (6 August, 2023)
Sandra Surya Rini, Gede Kambayana
LSO-073 Improvements and challenges of systemic lupus erythematosus associated pulmonary arterial hypertension: a 10-year multicenter cohort study (6 August, 2023)
Xingbei Dong, Junyan Qian, Jiuliang Zhao, Qian Wang, Mengtao Li, Xiaofeng Zeng
LSO-074 All-cause mortality and the incidence of cancer in patients with moderate-to-severe SLE: results from the British isles lupus assessment group biologics registry (BILAG-BR) (6 August, 2023)
Mia Rodziewicz, Sarah Dyball, Emily Sutton, Stephen Mcdonald, Ben Parker, Ian Bruce
LSO-075 Performance of conventional cardiovascular risk scores in identifying subclinical atherosclerosis in systemic lupus erythematosus (6 August, 2023)
Gayathri Ms, Chengappa Kavadichanda, Nived Haridas, Jaiveer Singh, Christina Mary Mariaselvam, Aishwarya Gopal, Molly Mary Thabah, Vir Singh Negi
LSO-106 Risk factors associated with the development of cardiovascular events in a multiethnic Asian systemic lupus erythematosus cohort (6 August, 2023)
Hwee Siew Howe
LSO-107 Association of hypertension with higher chronicity index scores among patients with lupus nephritis (6 August, 2023)
Peter Paolo Daleon, Wendell Oliver Española, Sandra Navarra
LSO-076 Understanding the genetic architecture of SLE from the perspective of associations from 14 other autoimmune diseases (6 August, 2023)
Wanling Yang, Xiao Dang, Yong-Fei Wang
LSO-077 Identification of an interferon 5-gene signature score as a pharmacodynamic and potential predictive biomarker for deucravacitinib treatment in a phase 2 trial in patients with systemic lupus erythematosus (6 August, 2023)
Chun Wu, Yanhua Hu, Mary K Crow, Amit Saxena, Christina Arriens, Coburn Hobar, Adrian Coles, Ian M Catlett
LSO-078 Clinical characteristics and genetic variants in a large cohort of monogenic lupus patients: emerging or fading frontiers? (6 August, 2023)
Sulaiman Al-mayouf, Alhanouf Alsaleem
LSO-079 Dynamic changes of immune cells in systemic lupus erythematosus with nephritis using longitudinal peripheral blood single-cell RNA-seq (6 August, 2023)
Seung-Jun Paek, Hye-Soon Lee, Ye Ji Lee, So-Young Bang, Bo-Kyeong Kang, Dae Jin Park, Young Bin Joo, Mimi Kim, Hyunsung Kim, Sung Yul Park, Woong-Yang Park, Kyu-Tae Kim, Sang-Cheol Bae
LSO-080 Machine-learning approach on lupus low disease activity prediction (6 August, 2023)
Nick Faelnar, Michael Tee, Cherica Tee, Jaime Caro, Geoffrey Solano, Rangi Kandane-Rathnayake, Angelene Therese Magbitang-Santiago, Evelyn Salido, Vera Golder, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, BMDB Basnayake, Madelynn Chann, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Shereen Oon, Sean O’Neill, Fiona Goldblatt, Kristine Ng, Annie Law, Nicola Tugnet, Sunil Kumar, Naoaki Ohkubo, Yoshiya Tanaka, Chak Sing Lau, Mandana Nikpour, Alberta Hoi, Eric Morand
LSO-081 Genomic prediction model using machine learning techniques that can distinguish autoimmune diseases (RA or SLE) from healthy controls (6 August, 2023)
Young Bin Joo, Youngho Park, So-Young Bang, Sang-Cheol Bae, Hye-Soon Lee
LSO-083 ‘Systemic lupus erythematosus women with lupus nephritis in pregnancy therapeutic challenge (SWITCH)’: the systemic lupus international collaborating clinics experience (6 August, 2023)
Joo-Young (Esther) Lee, Arielle Mendel, Anca Askanase, Sang-Cheol Bae, Jill Buyon, Ann E Clarke, Nathalie Costedoat-Chalumeau, Paul R Fortin, Dafna Gladman, Rosalind Ramsey-Goldman, John G Hanly, Murat Inanç, David Isenberg, Anselm Mak, Marta Mosca, Michelle Petri, Anisur Rahman, Jorge Sanchez-Guerrero, Murray Urowitz, Daniel Wallace, Sasha Bernatsky, Évelyne Vinet
LSO-084 Pregnancy outcomes in patients with systemic lupus erythematosus (SLE), anti-phospholipid antibody syndrome (APL), scleroderma (SSc) and rheumatoid arthritis (RA) at the Kenyatta national hospital, Nairobi, Kenya (6 August, 2023)
Paul Etau Ekwom, Fraciah Ruth Wangari, Margaret Kilonzo, Diana Ondieki
LSO-085 Nationwide patterns and factors associated with adverse pregnancy outcomes in women with systemic lupus erythematosus (6 August, 2023)
Yu-Seon Jung, Yeo-Jin Song, Jihyun Keum, Soo-Kyung Cho, Yoon-Kyoung Sung, Sun-Young Jung
LSO-086 Pregnancy outcomes in systemic lupus erythematosus: data from a multiethnic, multinational Latin American cohort (6 August, 2023)
Rosa M Serrano Morales, Romina Nieto, Rosana Quintana, Paula Alba, Sabrina Porta, Lucia Hernandez, Guillermo A Berbotto, Verónica Bellomio, Nilzio Antonio Da Silva, Odirlei Andre Monticielo, Fernando De Souza Cavalcanti, Francinne Machado Ribeiro, Eduardo F Borba, Eloisa Bonfa, Loreto Massardo, Gustavo Aroca Martinez, Andrés Cadena Bonfanti, Gerardo Quintana López, Mario Moreno, Jorge A Esquivel Valerio, María I Acosta, Astrid Paats Nicora, Claudia S Mora Trujillo, Marina Scolnik, Diana Fernandez, Carmen Funes Soaje, Verónica Saurit, Mercedes García, Eduardo Kerzberg, Graciela Gómez, Cecilia Pisoni, Edgard Torres dos Reis Neto, Iris Guerra Herrera, Oscar Neira Quiroga, Carlos A Cañas, Miguel A Saavedra Salinas, Margarita Portela Hernández, Hilda Fragoso Loyo, Luis H Silveira, Ignacio García de la Torre, Manuel Ugarte-Gil, Armando Calvo-Quiroz, Roberto Muñoz Louis, Ricardo Robaina, Vicente Juárez, Álvaro Danza, Carlos E Toro-Gutierrez, Carlos Abud Mendoza, Ana Malvar, Graciela S Alarcón, Ashley Orillion, Urbano Sbarigia, Federico Zazzetti, Guillermo J Pons-Estel, Bernardo A Pons-Estel
LSO-087 Sub-optimal use of anti-malarial therapy for SLE in the Asia Pacific region; observations from the Asia Pacific lupus cohort (6 August, 2023)
Rangi Kandane-Rathnayake, Alberta Hoi, Louthrenoo Worawit, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Jan Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, BMDB Basnayake, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Shereen Oon, Sang-Cheol Bae, Sean O’Neill, Fiona Goldblatt, Kristine (Pek Ling) Ng, Annie Hui Nee Law, Nicola Tugnet, Sunil Kumar, Naoaki Ohkubo, Michael Tee, Cherica Tee, Yoshiya Tanaka, Chak Sing Lau, Vera Golder, Mandana Nikpour, Eric Morand
LSO-088 Ld-IL2 synthesis with belimumab in the treatment of systemic lupus erythematosus patients (6 August, 2023)
Ruiling Feng
LSO-089 Effectiveness of belimumab in systemic lupus erythematosus patients of a multicenter Spanish cohort (6 August, 2023)
Irene Altabás-González, José María Pego-Reigosa, Coral Mouriño-Rodriguez, Norman Jiménez-Otero, Andrea Hernández-Martín, Judit Roman-Urgelles, Ivette Casafont-Sole, José Andrés Roman-Ivorra, Marta De la Rubia-Navarro, María Galindo-Izquierdo, Tarek Salman-Montes, Javier Narváez, Paola Vidal-Montal, María Jesús García-Villanueva, Sandra Garrote-Corral, María Ángeles Blázquez-Cañamero, Carlos Marras-Fernández, María Piqueras-García, Julia Martínez-Barrio, Marina Sánchez-Lucas, Josefina Cortés-Hernández, Eleonora Penzo, Jaime Calvo-Alen, Juan Ramón De Dios Jiménez de Aberásturi, Belén Álvarez-Rodríguez, Margarida Vasques Rocha, Eva Tomero, Raúl Menor-Almagro, Myriam Gandía-Martínez, José A Gómez-Puerta, Beatriz Frade-Sosa, Consuelo Ramos-Giráldez, Carmen Trapero-Pérez, Elvira Díez-Álvarez, Clara Moriano, Alejandro Muñoz-Jiménez, Íñigo Rúa-Figueroa
LSO-090 A placebo-controlled phase 1 study in healthy adult volunteers of the safety, tolerability, pharmacokinetics, and pharmacodynamics of povetacicept, a potent dual BAFF/APRIL antagonist, for the treatment of systemic lupus erythematosus (6 August, 2023)
Stacey Dillon
LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia (6 August, 2023)
Irina Murakhovskaya, Bruno Fattizzo, Tarek Ebrahim, YoungJa Lee, Kristen Sweet, Cathye Shu
LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials (6 August, 2023)
Sandra V Navarra, Peter Cornelisse, Clélia Cahuzac, Yoshinari Yokoyama, Osamu Togo, Ouali Berkani
LSO-093 Gut microbiota analysis in Korean patients with systemic lupus erythematosus (6 August, 2023)
Ji-Won Kim, Chang-Hee Suh, Hyoun-Ah Kim, Ju-Yang Jung
LSO-094 Analysis of microbiota in patients with systemic lupus erythematosus (6 August, 2023)
Junko Nishio, Hiroshi Sato, Eri Watanabe, Mai Kawazoe, Risa Wakiya, Soichi Yamada, Sei Muraoka, Shotaro Masuoka, Tomoki Hayashi, Satoshi Mizutani, Zento Yamada, Keiko Koshiba, Izumi Irita, Miwa Kanaji, Karin Furukawa, Nobuyuki Yajima, Hiroaki Dobashi, Wataru Hirose, Toshihiro Nanki
LSO-096 Analyzing the shared and specific genetic signals among 15 autoimmune diseases shed new light on the underlying causal genes and molecular mechanisms (6 August, 2023)
Xiao Dang, YongFei Wang, Wanling Yang
LSO-097 Captopril preventing blood brain barrier breach by anti-smith antibody (6 August, 2023)
Yoshiyuki Arinuma, Kenji Oku, Kunihiro Yamaoka
LSO-072 Comparison of COVID-19 vaccination with influenza vaccination in Korean patients with systemic lupus erythematosus: perception, adverse events, and flares from the CIVIL study (6 August, 2023)
Seonghoon Park, Seung Cheol Shim, Ji Soo Lee, Young Ho Lee, Seung-Ki Kwok, Yong-Gil Kim, Yong-Beom Park, Sung-Hwan Park, Sang-Cheol Bae, Chang Hee Suh, Yoon-Kyung Sung, Shin-Seok Lee, Chang-Keun Lee, Hye-Soon Lee, Seung Min Jung, Hoon-Suk Cha
LSO-109 Characteristics associated with poor COVID-19 outcomes in people with rheumatic disease: data from one single center from China (6 August, 2023)
Haihong Yao

E-Poster Presentation

LP-001 Antiphospholipid syndrome in juvenile systemic lupus erythematosus: the Malaysian experience (6 August, 2023)
La Reina Sangaran, Swee Ping Tang
LP-003 Antiphospholipid antibodies and recurrent thrombosis in primary antiphospholipid syndrome (6 August, 2023)
Reshetnyak Tatiana, Fariza Cheldieva, Anastasiiy Shumilova, Maria Cherkasova, Alexander Lila, Evgeny Nasonov
LP-004 Serum calprotectin could be a novel marker of microangiopathy in antiphospholipid syndrome patients (6 August, 2023)
Yuan Zhao, Wanting Qi, Yangzhong Zhou, Can Huang, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng
LP-009 Immunoglobulin gamma-3 subclass is a potential biomarker in seruma, saliva, and urine of patients with systemic lupus erythematosus (6 August, 2023)
Ji-Won Kim, Chang-Hee Suh, Ju-Yang Jung, Hyoun-Ah Kim, Wook-Young Baek, Sang-Won Lee
LP-012 Patients with systemic lupus erythematosus and hyperproduction of antibodies to anti-U1RNP (6 August, 2023)
Rushana Shayakhmetova, Lidia Ananyeva, Olga Koneva, Liudmila Garzanova, Olga Ovsyannikova, Oxana Desinova, Mayya Starovoytova
LP-013 Autoantibody trajectories associate with classification and treatment response in lupus nephritis (6 August, 2023)
Andrea Fava, Carla Guthridge, Joseph Kheir, Catriona Wagner, Michelle Petri, Jill Buyon, Betty Diamond, The Accelerating Medicine Partnership in ra/sle, Joel Guthridge, Judith James
LP-016 Anti-histone and anti-nucleosome antibodies, rather than anti-dsDNA antibodies are associated with interferon-induced biomarkers in Sudanese and Swedish SLE patients (6 August, 2023)
Sahwa Elbagir, NasrEldeen A Mohammed, Vilija Oke, Agneta Zickert, Anna Svanqvist, Christine Möller Westerberg, Anders Larsson, Jan Nilsson, Amir Elshafie, Elnour M Elagib, Musa AM Nur, Iva Gunnarsson, Elisabet Svenungsson, Johan Rönnelid
LP-203 The new markers of systemic lupus erythematosus activity: focus on interleukin (IL)-1b and soluble IL-2 receptor (6 August, 2023)
Mariia Aristova, Tatyana Panafidina, Yulia Gorbunova, Anastasiya Avdeeva, Tatyana Popkova
LP-019 Social maladjustment and anxiety-depressive spectrum disorders in system lupus erythematosus and primary antiphospholipid syndrome patients (6 August, 2023)
Anastasia Borisova, Yuriy Veltishchev, Tatyana Lisitsyna, Tatiana Reshetnyak, Olga Seravina, Oksana Kovalevskaya, Fariza Cheldieva, Anton Abramkin, Artur Zeltyn
LP-022 Preference and efficacy of zoledronate for the treatment of glucocorticoid-induced osteoporosis in patients with autoimmune disease including systemic lupus erythematosus (6 August, 2023)
Ji-Won Kim, Ju-Yang Jung, Hyoun-Ah Kim, Chang-Hee Suh
LP-023 Systemic lupus erythematosus concomitant with atopic dermatitis, a case series report (6 August, 2023)
Seon Young Song, Hae Chang Joh, Ki Yeon Kim, Mihn Sook Jue, Jeong Eun Kim, Joo Yeon Ko
LP-024 Colorectal duplication cyst with recto-vesica fistule in systemic lupus erythematosus patient (6 August, 2023)
Gede Perdana Putera, Deddy Nur Wachid Achadiono, Nyoman Kertiya, Ayu Paramaiswari
LP-025 Lipid spectrum and cholesterol content in circulating immune complexes in the blood of SLE patients (6 August, 2023)
Elena Gerasimova, Tatiana Popkova, Tatiana Panafidina, Liubov Kondrateva, Daria Gerasimova
LP-026 Obesity, hyperleptinemia and insulin resistance in women with systemic lupus erythematosus and rheumatoid arthritis (6 August, 2023)
Liubov Kondrateva, Tatiana Popkova, Tatiana Panafidina, Yulia Gorbunova, Elena Gerasimova
LP-027 Overweight and obesity phenotypes based on body mass index and insulin resistance in women with systemic lupus erythematosus (6 August, 2023)
Liubov Kondrateva, Tatiana Popkova, Yulia Gorbunova, Tatiana Panafidina, Elena Gerasimova
LP-029 Pediatric lupus erythematosus-an interdisciplinary challenge (6 August, 2023)
Rodica Olteanu, Ana Maria Cuciumita
LP-033 A study of treatment satisfaction in the patients with rheumatoid arthritis and systemic lupus erythematous (6 August, 2023)
Hyo-Jin Choi, Mi Ryoung Seo, Han Joo Baek
LP-038 Infection in systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a potential key to improve outcomes (6 August, 2023)
Mucong Li, Wei Bai, Yanhong Wang, Lan Song, Shangzhu Zhang, Jiuliang Zhao, Chanyuan Wu, Mengtao Li, Xinping Tian, Xiaofeng Zeng
LP-039 Long-term outcome related with initial clinical parameters in juvenile systemic lupus erythematosus: retrospective study (6 August, 2023)
Dae Chul Jeong, Soo Young Lee, Jung Woo Rhim, Pil Sang Jang, Yoon Hong Jeon, Jung Hyun Lee, Jung Hee Koh, Gui Young Kang, Kyung Soo Park, Ho Wook Jeon, Sung Hwan Park
LP-044 A comparative study on the effect of high-dose dexamethasone pulse therapy versus methylprednisolone pulse therapy in systemic lupus erythematosus patients admitted at bicol medical center (6 August, 2023)
Aileen Billones, Richard John Pelo
LP-047 Bilateral pallidal lesions in a patient with neuropsychiatric lupus patient: a case report (6 August, 2023)
Yan-Siang Huang, Chien-Sheng Wu
LP-048 Characteristics and clinical outcome of incomplete systemic lupus erythematosus (6 August, 2023)
Tatiana Panafidina, Tatiana Popkova, Liubov Kondrateva, Yulia Gorbunova, Anastasiia Shumilova, Evgeniy Nasonov, Alexandr Lila
LP-050 Recurrent seizures as a wake-up call for SLE diagnosis in a limited resource setting (6 August, 2023)
Radhiyatam Mardhiyah
LP-053 Dietary and life-style habits of patients with gastrointestinal involvement of systemic lupus erythematosus (6 August, 2023)
Haojie Xu, Xia Meng, Lu Wang, Lidan Zhao
LP-054 Serious infections among thai patients with systemic lupus erythematosus: data from the LUCRA cohort (6 August, 2023)
Rattapol Pakchotanon, Nichakorn Pidet
LP-055 The effect of different remission definitions in patients with systemic lupus erythematosus on damage accrual: data from the LUCRA cohort (6 August, 2023)
Rattapol Pakchotanon, Patamarwadee Chitpet, Sumapa Chaiamnuay, Pongthorn Narongroeknawin, Paijit Asavatanabodee
LP-056 Pseudo-pseudo meigs syndrome or tjalma syndrome: an initial presentation in a young female with Systemic lupus erythematosus (6 August, 2023)
Chad Kevin Fernandez, John Elmer Quilisadio
LP-058 The involvement of scalp and nails in cutaneous lupus erythematosus patients: a retrospective study (6 August, 2023)
Jin Hyun Jang, Hae Chang Joh, Ki Yeon Kim, Mihn Sook Jue, Jeong Eun Kim, Joo Yeon Ko
LP-059 Association of seasonal vitamin D levels and disease activity in patients with systemic lupus erythematosus (6 August, 2023)
Ji-Won Kim, Ju-Yang Jung, Hyoun-Ah Kim, Chang-Hee Suh
LP-060 Extracellular vesicular proteins in plasma from patients with cutaneous lupus correlate with disease activity (6 August, 2023)
Mariko Momohara
LP-061 Male sex and disease activity at diagnosis are predictors of severe hemolytic anemia in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort (6 August, 2023)
Luis A González, Graciela S Alarcón, Guillermina B Harvey, Rosana Quintana, Guillermo J Pons-estel, Manuel F Ugarte-gil, Gloria Vásquez, Luis J Catoggio, Mercedes A García, Eduardo F Borba, Nilzio A Da silva, C João, Marlene Guibert toledano, Loreto Massardo, Oscar Neira, Virginia Pascual-ramos, Mary-Carmen Amigo, Leonor A Barile-fabris, Ignacio García de la torre, José Alfaro-lozano, María I Segami, Rosa Chacón-díaz, María H Esteva-spinetti, Antonio Iglesias-gamarra, Bernardo A Pons-estel
LP-062 Two-year outcomes by belimumab additive on standard of care in patients with systemic lupus erythematosus: a single center retrospective cohort study (6 August, 2023)
Yoshiyuki Arinuma, Hirotomo Asakura, Yasuhiro Hasegawa, Tomoki Tanaka, Yu Matsueda, Tatsuhiko Wada, Kenji Oku, Kunihiro Yamaoka
LP-063 Clinical characteristics and outcomes of libman sacks endocarditis in patients with systemic lupus erythematosus (6 August, 2023)
Eunsong Kang, Joo Hyang Chun, Soo Min Ahn, Ji Seon Oh, Yong Gil Kim, Chang Keun Lee, Bin Yoo, Seokchan Hong
LP-064 Effect of osteoporosis on major adverse cardiovascular events (MACEs) in systemic lupus erythematosus (SLE): a longitudinal study (6 August, 2023)
Chi-Chiu Mok, Kar Li Chan, Ling Yin Ho, Chi Hung To
LP-065 Prevalence and risk factors of fragility fractures in systemic lupus erythematosus (SLE): a longitudinal study over 12 years (6 August, 2023)
Chi-Chiu Mok, Kar Li Chan, Ling Yin Ho, Chi Hung To
LP-066 Severe Systemic lupus erythematosus with manifestation of lupus nephritis and pericardial effusion: a case report (6 August, 2023)
Arief Nurudhin, Yulyani Werdiningsih, Nurhasan Agung Probowo, Alwida Rosyid A.p, Indrayana Sunarso
LP-067 Analysis of hospital length of stay in systemic lupus erythematosus patients hospitalised with infection (6 August, 2023)
Anant Butala, Ning Li, Alberta Hoi
LP-204 Chilblain lupus erythematosus-a rare encounter (6 August, 2023)
Mohamed Shafi Mahboob Ali
LP-206 ANA-negative lupus presenting with segmental hyalinizing vasculitis and valvular heart disease – a rare case report (6 August, 2023)
Widya Inarah Nadhilah Hamid, Femi Syahriani, Faridin Pango, Abdul Rahman Umar, Endy Adnan
LP-068 The challenges in the management of systemic lupus erythematosus during the 3rd wave of COVID19 pandemic in Sri Lanka: a single-centre experience (6 August, 2023)
Chathurika Dandeniya
LP-069 Update of the epidemiology and mortality of juvenile onset SLE and pediatric SLE in Italy (6 August, 2023)
Margherita Zen, Laura Salmaso, Ilenia Anna Gennaio, Claudio Barbiellini Amidei, Ugo Fedeli, Mario Saia, Andrea Doria
LP-070 Medication compliance in systemic lupus erythematosus: community-based study in Surakarta, Indonesia (6 August, 2023)
Indrayana Sunarso, Ariana Setiani, Arief Nurudhin, Yuyani Werdiningsih
LP-071 Accuracy of disease-specific ICD-10 code for incident systemic lupus erythematosus; results from a population-based cohort study set in Norway (6 August, 2023)
Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, Torhild Garen, Antonella Botea, Nenad Damjanic, Gro Wivestad, Heidi Kverneggen Øvreås, Thea Bøe, Anniken Orre, Sella Aarrestaad Provan, Øyvind Molberg, Karoline Lerang
LP-072 Validity of a claim-based algorithm for SLE disease severity to clinical SLE disease activity index in Korean patients with SLE (6 August, 2023)
Hyoungyoung Kim, Eunwoo Nam, Sun-Young Jung, Eun Jin Jang, Yoon-Kyoung Sung, Soo-Kyung Cho
LP-073 Identification of systemic lupus erythematosus classification criteria attributes in a regional medical record data network (6 August, 2023)
Noah Forrest, Kathryn Jackson, Jennifer Pacheco, Vesna Mitrovic, Alona Furmanchuk, Abel Kho, Rosalind Ramsey-goldman, Theresa Walunas
LP-074 Cost-of-illness changes before and after diagnosis of systemic lupus erythematosus: a nationwide population-based cohort study in Korea (6 August, 2023)
Hyoungyoung Kim, Soo-Kyung Cho, Jung-Yong Han, Yena Jeon, Sun-Young Jung, Eun Jin Jang, Yoon-Kyoung Sung
LP-078 Characterization of a cohort of patients with a diagnosis of systemic lupus erythematosus followed-up in the city of Cali, Colombia (6 August, 2023)
Diana Fernández, Daniel Fernández, John Jaramillo, Alfredo Vargas, Carlos Toro
LP-082 Effects of rosuvastatin for the treatment in lupus-prone mice (6 August, 2023)
Wook-Young Baek, Sang-Won Lee, Seung-Ju Kim, Chang-Hee Suh
LP-083 Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Faslpr mice (6 August, 2023)
Hong Kyung Lee, Sang-Bae Han
LP-084 Single cell genomics of self-reactive B cells in systemic lupus erythematosus (6 August, 2023)
Joanne Reed
LP-085 Investigating the therapeutic potential of achatina fulica snail mucus on pristane-induced lupus nephritis in mice (6 August, 2023)
Arief Nurudhin, Yulyani Werdiningsih, Idhil Akbar, Fatichati Budiningsih, Nurhasan Agung Probowo, Arfin Arifin, Indrayana Sunarso
LP-086 Dexamethasone-incorporated immunomodulatory PDMAEMA-PLGA nanoparticles potentially induced tolerogenic dendritic cells and ameliorated lupus disease by mediating antigen-specific immune tolerance (6 August, 2023)
Phuriwat Khiewkamrop, Chonnavee Manipuntee, Chamraj Kaewraemruaen, Numpon Insin, Asada Leelahavanichkul, Nattiya Hirankarn, Patcharee Ritprajak
LP-087 LILRA3 plays a protective role in MAS-like disease (6 August, 2023)
Chen Chen, Yundi Tang, Hongjiang Liu, Chun Li, Jianping Guo
LP-088 IL-21 regulating age-associated B cells (ABCs) drive autoimmune disease phenotype in aged mice (6 August, 2023)
Jeein Oh, Ye-JI Kim, Youn Soo Choi
LP-089 Role of inflammatory cytokines, IL-6 and the correlation with ratio of IL-6 and IL-17 serum cytokines in active systemic lupus erythematosus patients (6 August, 2023)
Dwitya Elvira
LP-091 Neutrophil extracellular traps in APS and SLE (6 August, 2023)
Kamila Nurbaeva, Tatiana Reshetnyak, Margarita Kuzina, Irina Vasilenko, Aleksander Lila
LP-092 Interferon stimulated genes in CD4 T cells are associated with pyroptosis pathways in patients with lupus (6 August, 2023)
Sang Jin Lee
LP-093 Role of leukocyte immunoglobulin-like receptor a3 (LILRA3) in the pathogenesis of lupus-like disease (6 August, 2023)
Yundi Tang, Chen Chen, Jianping Guo
LP-094 Repression of Id3 aggravates lupus phenotypes in murine models via aberrant B cell differentiation (6 August, 2023)
Youngjae Park, Da Som Kim, Mi-La Cho, Seung-Ki Kwok
LP-095 Macrophage activation in untreated patients with systemic lupus erythematosus (PRELIMINARY DATA) (6 August, 2023)
Elena Gerasimova, Tatiana Popkova, Tatiana Kirichenko, Alexander Markin, Anastasia Bogatyreva
LP-096 Plasmablast-like antigen-experienced CXCR5- CD19low B cells are expanded in systemic lupus erythematosus (6 August, 2023)
Franziska Szelinski, Ana-Luisa Stefanski, Eva Vanessa Schrezenmeier, Hector Rincon-arevalo, Annika Wiedemann, Karin Reiter, Jacob Ritter, Marie Lettau, Duc Van Dang, Sebastian Fuchs, Andreas P Frei, Tobias Alexander, Andreia C Lino, Thomas Dörner
LP-097 Degranulating PR3+ myeloid cells characterize proliferative lupus nephritis (6 August, 2023)
Alessandra Ida Celia, Xiaoping Yang, Michelle Petri, Avi Rosenberg, Andrea Fava
LP-098 Proteomic analysis of histological lesions in lupus nephritis identifies an inflammatory signature of fibrous crescents (6 August, 2023)
Alessandra Ida Celia, Jeffrey Hodgin, Dwita Demeke, Avi Rosenberg, Laurence S Magder, Jill Buyon, Betty Diamond, Judith James, William Apruzzese, Paride Fenaroli, Derek Fine, Jose Monroy-Trujillo, Mohamed G Atta, Peter Izmirly, Michael Belmont, Anne Davidson, Daniel W Goldman, Accelerating Medicines Partnership (AMP) Ra/sle, Michelle Petri, Andrea Fava
LP-210 Peripheral blood b-cell subsets in patients with systemic lupus erythematosus (6 August, 2023)
Tatyana Popkova, Andrey Aleksankin, Anastasia Avdeeva, Valeriia Rybakova, Evgeniy Nasonov
LP-099 High genetic risk loads increase the risk of lupus nephritis in Koreans (6 August, 2023)
Young-Chang Kwon, Eunji Ha, Hyuk-Hee Kwon, Dae Jin Park, Jung-Min Shin, Young Bin Joo, Won Tae Chung, Dae-Hyun Yoo, Hye-Soon Lee, Kwangwoo Kim, Sang-Cheol Bae, So-Young Bang
LP-102 Understanding human disease mutations through gene editing and genome-wide next generation investigations (6 August, 2023)
Hye Kyung Lee, Lothar Hennighausen
LP-103 Annotation of cell-type specific differences in the Function of the SLE-associated gene IKZF2, using ChIP-Seq (6 August, 2023)
Deborah Cunninghame Graham, Christopher Odhams, Andrea Cortini, Sarah Karrar, Timothy Vyse
LP-105 Synergistic effect of extra X chromosome in the development of systemic lupus erythematosus in klinefelter syndrome karyotype 47, XXY and karyotype 47, XXX females (6 August, 2023)
Irene J Tan, Pushti Khandwala, Mitali Sen
LP-110 Development of GSTA1, CYP2C19, and CYP2B6 gene polymorphism detection methods on the response of cyclophosphamide therapy for lupus nephritis patients (6 August, 2023)
Yen Yen Ari Indrawijaya, Maria Immaculata Iwo, Aluicia Anita Artarini, Laniyati Hamijoyo
LP-112 A case of macrophage activation syndrome in neonatal lupus (6 August, 2023)
JUNG-WOO Rhim, Soo Young Lee, HYUNMI Kang, Ye Ji Kim, In Hyuk Lyu, DAE-CHUL Jeong
LP-113 Systemic lupus erythematosus induced by experimental therapy with a combination of monoclonal antibodies against the sars-cov2 surface s-protein (6 August, 2023)
Mariia Aristova, Tatiana Panafidina, Tatiana Popkova, Anna Misiyuk, Magomed Kurbanmagomedov
LP-114 Lupus and multiple sclerosis may share an initiating pathogenesis: the anti- EBNA1 heuristic conjecture (6 August, 2023)
John B Harley, Dennis H Clark, Iouri Chepelev, Kenneth M Kaufman, Viktoryia Laurynenka, Isaac TW Harley
LP-116 To get, or not to get: risk and benefit of COVID-19 vaccine in Korean patients with systemic lupus erythematosus (6 August, 2023)
Seonghoon Park, Ji Soo Lee, Young Ho Lee, Seung-Ki Kwok, Yong-Gil Kim, Yong-Beom Park, Sung-Hwan Park, Sang-Cheol Bae, Chang Hee Suh, Yoon-Kyung Sung, Shin-Seok Lee, Chang-Keun Lee, Hye-Soon Lee, Seung Min Jung, Hoon-Suk Cha, Seung Cheol Shim
LP-117 A case report of a 22 year old Filipino male diagnosed SLE who was infected with HIV-AIDS and COVID 19 moderate disease (6 August, 2023)
Petersian Alcazaren, Helmar Soldevilla
LP-118 Assessment of systemic lupus erythematosus activity and remission: SLEDAI-2k or SLE-DAS – which to choose? (6 August, 2023)
Anastasiia Shumilova, Fariza Cheldieva, Tatiana Reshetnyak
LP-119 Thalassemia traits in systemic lupus erythematosus patients with anemia (6 August, 2023)
Edhyana Sahiratmadja, Laniyati Hamijoyo, Regina Chintya Fani, Delita Prihatni
LP-124 Childhood-onset lupus nephritis: real world long-term outcome data from a single center (6 August, 2023)
Jiwon Jung, Joo Hoon Lee, Suk Chan Hong
LP-125 Glomerulonephritis in systemic lupus erythematosus: ‘not everything is lupus’ a case series (6 August, 2023)
Diana Páez, Nilmo Chávez, Estuardo Anzueto, Silvia Rivera, Gilbert Martínez, Valeria Rodríguez, Otsar González, Alejandra Felipe, Luis Gómez, William Recinos
LP-126 The infectious complication in multitarget therapy of class V lupus nephritis: a case report (6 August, 2023)
Tatiana Panafidina, Tatiana Popkova, Anastasiia Shumilova, Aleksandr Lila
LP-127 Tacrolimus is effective treatment in patients with refractory lupus nephritis (6 August, 2023)
Ji-Won Kim, Ju-Yang Jung, Hyoun-Ah Kim, Chang-Hee Suh
LP-128 Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis (6 August, 2023)
Young Ho Lee, Gwan Gyu Song
LP-129 Lupus low disease activity state as an attainable and complementary target for lupus nephritis (6 August, 2023)
Chak Kwan Cheung, Shirley Chiu Wai Chan, Chak Sing Lau
LP-131 Serum uric acid and the risk of renal involvement in premenopausal female systemic lupus erythematosus patients (6 August, 2023)
Su Jin Choi, Seung Won Choi, Doo-Ho Lim
LP-133 Baseline clinical characteristics of SLE patients compared to those with lupus nephritis and on renal replacement treatment (RRT) including kidney transplantation (6 August, 2023)
Rajaie Namas, Sarah Al Qassimi, Amir Malik, Muriel Ghosn, Lara Memisoglu, Hani Shatnawi, Mohamed Elarabi, Nizar Attallah
LP-207 Impact of time to remission, flares and time on immunosuppressives on the estimated glomerular filtration rate in lupus nephritis (6 August, 2023)
Konstantinos Tselios, Dafna Gladman, Jiandong Su, Murray Urowitz
LP-208 Mesangial lupus nephritis: long term outcomes (6 August, 2023)
Konstantinos Tselios, Dafna Gladman, Jiandong Su, Murray Urowitz
LP-135 High neutrophil-to-lymphocyte ratio is a risk factor for chronic kidney disease in patients with lupus nephritis (6 August, 2023)
Dong-Jin Park, Hyemin Jeong, Sung-Eun Choi, Ji-Hyoun Kang, Shin-Seok Lee
LP-136 A 52 year old female with abdominal pain and diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and probable systemic lupus erythematosus: a case report (6 August, 2023)
Kimberly Yu, Rosario Baes
LP-137 Benefits of ANA screening for NPSLE in patients admitted to the department of psychiatry (6 August, 2023)
Yeo-Jin Lee, Soo Min Ahn, Seokchan Hong, Ji Seon Oh, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim
LP-138 Predictors for future development of systemic lupus erythematosus in Korean sjögren’s syndrome patients (6 August, 2023)
Bong-Woo Lee, Eui-Jong Kwon, Youngjae Park, Jennifer Jooha Lee, Sung-Hwan Park, Seung-Ki Kwok
LP-139 Baseline characteristics of a longitudinal, multinational, multiethnic study of lupus patients, with or without lupus nephritis (6 August, 2023)
Romina Nieto, Rosana Quintana, Eduardo F Borba, Lucia Hernández, Diana Fernández-Ávila, Laura Maurelli, Paula Alba, Florencia Bordón, Fernando Arizpe, Guillermo Berbotto, Rosa Serrano-Morales, María Constanza Bertolaccini, Eduardo Kerzberg, María de los Ángeles Gargiulo, Anabella Rodríguez, Vitalina Sousa Barbosa, Fernando Cavalcanti, Laissa Cristina Alves Alvino, Luciana Parente Costa Seguro, Lucas Victoria De Oliveira Martins, Oscar Neira, Loreto Massardo, Gustavo Aroca Martínez, Ivana Nieto Aristizábal, A Paul, Antonio Iglesias Gamarra, Andrés Zuñiga Vera, Olga Vera lastra, Mario Pérez cristóbal, Eduardo Martín-Nares, Luis Amezcua-guerra, Yelitza González-Bello, José Octavio González Enriquez, Dionicio Galarza-Delgado, Carolina Vázquez Vázquez, Marcelo Barrios, Magaly Alba Linares, Cristina Reategui, Ana Mabel Quirós-alva, Teresandris Polanco, Carina Pizzarossa, Martín Rebella, María Elena Crespo, Álvaro Danza, Eloisa Bonfa, Graciela S Alarcón, Federico Zazzetti, Ashley Orillion, Urbano Sbarigia, Guillermo J Pons-Estel
LP-141 Delay to diagnosis of systemic lupus erythematosus and its impact on cumulative damage and mortality: data from a multiethnic Latin American cohort (6 August, 2023)
Romina Nieto, Rosana Quintana, Ernesto Zavala, Rosa Maria Serrano Morales, Karen Roberts, Guillermina B Harvey, Eduardo Acevedo-Vásquez, Leonor Barile, Lilian Lavras Costallat, Oscar Neira, Rosa Chacon, Nílzio Da Silva, José Fernando Molina-Restrepo, Antonio Iglesias Gamarra, Graciela S Alarcon, Bernardo Pons-Estel, Guillermo Pons-Estel
LP-143 A case of Systemic lupus erythematosus in a male patient presenting with mouth bleeding and cutaneous manifestation (6 August, 2023)
Mariam Amanda Kostansia Mauko
LP-144 Cytosolic localization of antibodies in monocytes is positively associated with disease activity of the patients with systemic lupus erythematosus (6 August, 2023)
Minjae Kim, Youngsil Seo, Juho Choi, Yerin Jeon, Young-In Noh, Eunbin Lee, Ju-Yang Jung, Myung-Hee Kwon
LP-145 Case report: a 43-year-old Filipino with lupus myocarditis as initial presentation of systemic lupus erythematosus (6 August, 2023)
Mark Ledge Gerona, Gaea Isabel Trazo, Rosario Baes
LP-149 Latin-American systemic lupus erythematosus clusters (6 August, 2023)
Rosana Quintana, Romina Nieto, Guillermo J Pons-Estel, José Gómez Puerta, Guillermina Harvey, Marina Scolnik, Nidia Meras, Cintia Otaduy, Elisa Novati, Valeria Arturi, María Emilia Sattler, Luciana González Lucero, Wilfredo Patiño Grageda, Nicolás Pérez, Cecilia Pisoni, Ana Carolina De Oliveirae Silva Montaton, Odirlei Andre Monticielo, Angela Duarte, Francinne Machado Ribeiro, Emily Figueiredo Neves Yuki, Edgard Torres Dos Reis-Neto, Iris Guerra, Milena Mimica Davet, Gustavo Aroca Martínez, Gabriel J Tobón, Gerardo Quintana-Lopez, Andrés Cadena Bonfanti, Mario Moreno Álvarez, Miguel Angel Saavedra Salinas, Margarita Portela Hernández, Hilda Fragoso Loyo, Luis H Silveira, Ignacio García valladares, Carlos Abud Mendoza, Jorge A Esquivel-Valerio, Maria Teresa Martinez, Margarita Duarte, Claudia Selene Mora Trujillo, Manuel Ugarte-Gil, S Ernesto, Roberto Muñoz louis, Ricardo Robaina, Vicente Juarez, Gonzalo Silveira, Eduardo Borba, Luis J Catoggio, Graciela S Alarcón, Federico Zazzetti, Ashley Orillion, Urbano Sbarigia, Bernardo A Pons-Estel
LP-150 Outcomes of serologically active clinically quiescent (SACQ) versus serologically and clinically quiescent (SQCQ) statuses in patients with systemic lupus erythematosus (6 August, 2023)
Rattapol Pakchotanon, Chonlamark Rattanakom
LP-153 The potential role of serum cytoskeleton-associated protein 4 as a novel biomarker to monitor disease activity in systemic lupus erythematosus (6 August, 2023)
Yuki Kudo, Michihito Kono, Olga Amengual, Tatsuya Atsumi
LP-154 Peripheral gangrene in systemic lupus erythematosus – a rare case report (6 August, 2023)
Nurul Fadhilah, Faridin Pango, Femi Syahriani, Endy Adnan, Abdul Rahman Umar
LP-155 Psychosis as an early manifestation of neuropsychiatric systemic lupus erythematosus – a case report (6 August, 2023)
Widya Wirasasmita Mirsan, Femi Syahriani, Faridin Pango, Endy Adnan, Abdul Rahman Umar
LP-157 Progressive discoid lupus related severe vasculitis – a rare case report (6 August, 2023)
Ika Saputri Burhanuddin, Faridin Pango, Femi Syahriani, Endy Adnan, Abdul Rahman Umar
LP-159 Studying the disease activity and the degree of internal organ damage in systemic lupus erythematosus patients in the Kazakh population (6 August, 2023)
Гульжан Алибекова, Nataliya Zemlyanskaya, Gulmira Derbissalina, Galymzhan Togizbayev
LP-161 Tjalma syndrome (Pseudo-Pseudo Meigs Syndrome): polyserositis with increased CA-125 in patients with systemic lupus erythematosus (6 August, 2023)
Dinar Faricy Yaddin, Laniyati Hamijoyo
LP-162 Prognostic factors for the chronic thrombocytopenia in systemic lupus erythematosus (6 August, 2023)
Soo Min Ahn, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Seokchan Hong
LP-167 Uncommon initial presentations of SLE – a case series (6 August, 2023)
Madusha Jayasinghe, Duminda Abeysinghe
LP-168 Prevalence and association of autoantibodies with latent tuberculosis in first-degree relatives of patients with systemic lupus erythematosus (6 August, 2023)
Gayathri Ms, Abilasha Narayanan, Chengappa Kavadichanda, Molly Mary Thabah, Sonali Sarkar, Prakash Babu Narasimhan
LP-170 Predictors of neuropsychiatric flares In Patients With Systemic Lupus Erythematosus: Results From Five Phase III clinical trials of belimumab (6 August, 2023)
Leonardo Palazzo, Julius Lindblom, Nursen Cetrez, Henri Ala, Ioannis Parodis
LP-171 Fibromyalgia and glucocorticoids use drives self-perceived depression in systemic lupus erythematosus: insights from a large prospective and multicenter study using Relesserpros register’s database. (6 August, 2023)
Iñigo Rúa-Figueroa, Julia Martínez-Barrio, Norman Jiménez, María Galindo-Izquierdo, Esther Uriarte-Isacelaya, Antonio Fernandez-Nebro, Jaime Calvo, Sara Manrique-Arija, Jose Rosas, Rocio Caño-Alameda, J. Narváez, Inmaculada Ros, Elena Aurrecoechea, Vicenç Torrente-Segarra, Clara Sanguesa, Mercedes Freire-González, Eva Tomero-Muriel, Loreto Horcada, Clara Moriano, Mireia Moreno, Carlota Laura-Iñíguez, Ricardo Blanco, Ana Pérez-Gómez, José Luis Andréu-Sánchez, Sandra Garrote-Corral, Santiago Muñoz-Fernández, Gema Bonilla, Nuria Lozano-Rivas, Carlos A Montilla-Morales, O Ibarguengoitia, Lorena Expósito, Elia Vals-Pascual, Angela Pecondon-Español, Sergio Machín, Eva Salgado-Perez, Maria Celia-Erausquin, Tarek Carlos Salman-Monte, Raúl Menor-Almagro, Alejandro Muñoz-Jimenez, Irene Altabás-González, Jorge Juan Fragío-Gil, Jose María Pego-Reigosa
LP-173 Systemic lupus erythematosus and associated pulmonary arterial hypertension: discussion of own data (6 August, 2023)
Natalia Yudkina, Alexander Volkov
LP-174 Factors affecting SLICC damage index score in systemic lupus erythematosus patients in hasan sadikin general hospital, Indonesia (6 August, 2023)
Hans Albertus, Nadia Gita Ghassani, Laniyati Hamijoyo
LP-175 Frequencies, clinical characteristics and prognosis of patients with neuropsychiatric systemic lupus erythematosus (6 August, 2023)
Shirley Chiu Wai Chan, Chak Sing Lau
LP-176 SARS-CoV-2 antibody formation after COVID-19 vaccination in SLE patients treated with belimumab: single-center prospective observational study (6 August, 2023)
Eunsong Kang, Soo Min Ahn, Seokchan Hong, Ji Seon Oh, Chang Keun Lee, Bin Yoo, Yong Gil Kim
LP-211 Disease manifestations and outcomes in juvenile and adult onset SLE – a nested case control study within a singapore cohort (6 August, 2023)
Hwee Siew Howe
LP-200 Relapsing polychondritis and systemic lupus erythematosus overlap in a 26 year old G2P1 pregnant mother with successful pregnancy outcome (6 August, 2023)
Adel Taradji, Melchor Siriban, Marlon Loquias
LP-179 Design of 2 phase 3, double-blind, placebo-controlled, global trials of deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with active systemic lupus erythematosus (6 August, 2023)
Cristina Arriens, Anca Askanase, Richard Furie, Eric Morand, Ronald van Vollenhoven, Kevin Connors, Monica Davey, Nikolay Delev, Vaishali Shah, Anna Stevens, Thomas Wegman, Coburn Hobar
LP-180 Design of a phase 2, double-blind, placebo-controlled, global trial of deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with active discoid and/or subacute cutaneous lupus erythematosus (6 August, 2023)
Victoria P Werth, Joseph F Merola, Joerg Wenzel, Nikolay Delev, Harini Kothari, Richard Meier, Shalabh Singhal, Malavi Madireddi, Shimon Korish
LP-181 Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus (6 August, 2023)
Masato Okada
LP-182 Pharmacokinetics, selectivity profile, and exposure-response relationship for efficacy and safety in a phase 2 study of deucravacitinib, an oral, selective, allosteric TYK2 inhibitor, in patients with systemic lupus erythematosus (6 August, 2023)
Takafumi Ide, Manoj Chiney, Huynh Yen Thanh Bach, Vineet Goti, Bindu Murthy, Coburn Hobar, Qihong Zhao, Urvi Aras
LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW) (6 August, 2023)
Eric F Morand, Victoria P Werth, Andrew Bender, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Cristina Vazquez-mateo, Melinda Przetak, Flavie Moreau, Mukhy Khursheed, Sanjeev Roy, David R Pearson
LP-184 Rationale and design of two phase 3, Randomized, double-blind, placebo-controlled studies of the efficacy and safety of litifilimab in adults with active systemic lupus erythematosus: TOPAZ-1 and TOPAZ-2 (6 August, 2023)
Ronald FVan vollenhoven, Richard A Furie, Eric F Morand, Kenneth Kalunian, Maria Dall’era, Stacey Goode-sellers, Puja Joshi, George Kong, Ting Wang, Xing Wei, Youmna Lahoud, Catherine Barbey
LP-185 Treatment of cutaneous lupus erythematosus with energy based devices (6 August, 2023)
Jin Hyun Jang, Yun Jung Huh, Ki Yeon Kim, Mihn Sook Jue, Jeong Eun Kim, Joo Yeon Ko
LP-186 Initial experience with belimumab In SE Asian lupus patients – a report of 6 patients (6 August, 2023)
YOONKam hon, Wong Nadia
LP-187 Abstract withdrawn (6 August, 2023)
LP-188 Glucocorticoids withdrawn in systemic lupus erythematosus patients with serologically active clinically quiescent state: a desirable goal (6 August, 2023)
Yufang Ding, Jiuliang Zhao, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng
LP-189 Effect of belimumab in patients with systemic lupus erythematosus treated with minimal or no steroid (6 August, 2023)
Yeo-Jin Lee, Soo Min Ahn, Seokchan Hong, Ji Seon Oh, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim
LP-190 Successful treatment of rituximab and bortezomib in refractory systemic lupus erythematosus: a case report (6 August, 2023)
Chen Chen, Yifan Wang, Hongjiang Liu, Yundi Tang, Jianping Guo, Chun Li
LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort (6 August, 2023)
Irene Altabás-González, José María Pego-Reigosa, Coral Mouriño-Rodriguez, Norman Jiménez-Otero, Andrea Hernández-Martín, Judit Font-Urgelles, Ivette Casafont-Sole, José Andrés Roman-Ivorra, Marta De La Rubia-Navarro, María Galindo-Izquierdo, Tarek Salman-Montes, Javier Narváez, Paola Vidal-Montal, María Jesús García-Villanueva, Sandra Garrote-Corral, María Ángeles Blázquez-Cañamero, Carlos Marras-Fernández, María Piqueras-García, Julia Martínez-Barrio, Marina Sánchez-Lucas, Josefina Cortés-Hernández, Eleonora Penzo, Jaime Calvo-Alen, Juan Ramón De Dios Jiménez De Aberásturi, Belén Álvarez-Rodríguez, Margarida Vasques-Rocha, Eva Tomero, Raúl Menor-Almagro, Myriam Gandía-Martínez, José A Gómez-Puerta, Consuelo Ramos-Giráldez, Carmen Trapero-Pérez, Elvira Díez-Álvarez, Clara Moriano, Alejandro Muñoz-Jiménez, Íñigo Rúa-Figueroa
LP-195 Design of a Phase 2 study evaluating the efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus (6 August, 2023)
Fang Liu-walsh, Bart van Hartingsveldt, Qing Zuraw, Robert Hoffman, Terence Rooney, Sheng Gao, YoungJa Lee, Robert Gordon, Jocelyn Leu, Cesar Calderon, Federico Zazzetti, Anne Stevens, George Vratsanos
LP-196 Low-dose IL-2 therapy in SLE: efficacy on organ involvement, response predictors and synergistic effects with glucocorticoid treatment (6 August, 2023)
Xiaolin Sun, Miao Miao, Jing He, Zhanguo Li
LP-197 Association between steroid therapy and IGRA Result in systemic lupus erythematosus (6 August, 2023)
Naurah Alzena Hana Dhea, Guntur Darmawan, Alya Dharmaninda, Edhyana Sahiratmadja, Laniyati Hamijoyo
LP-198 Clinical response by subgroups in patients with systemic lupus erythematosus (SLE) receiving standard of care treatment plus placebo (SOC+PBO): a post hoc analysis from clinical trial data (6 August, 2023)
Christian Stach, Caroline Gordon, Vanessa Taieb, George Stojan, Joan T Merrill
LP-199 Medications given to patients with incomplete systemic lupus erythematosus (6 August, 2023)
Tatiana Panafidina, Tatiana Popkova, Liubov Kondrateva, Yulia Gorbunova, Anastasiia Shumilova, Alexandr Lila
LP-212 SLE overlap with psoriatic arthritis successfully treated with secukinumab (6 August, 2023)
Athina Theodoridou

Author Index

Author index (6 August, 2023)

Main menu

Table of contents

2023 - Volume 10 - Suppl 1

The 15th International Congress on Systemic Lupus Erythematosus and The 43rd KCR Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)

Organizing Committee

Oral Presentation

Short Oral Presentation

E-Poster Presentation

Author Index

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

2023 - Volume 10 - Suppl 1

The 15th International Congress on Systemic Lupus Erythematosus and The 43rd KCR Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)

Organizing Committee

Oral Presentation

Short Oral Presentation

E-Poster Presentation

Author Index

Issue Information